Interleukin-6 inhibits growth hormone-mediated gene expression in hepatocytes

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 292, Issue 6, 2007, Pages

  Ahmed, Tamer A ^a   Buzzelli, Mark D ^a   Lang, Charles H ^a   Capen, John B ^a   Shumate, Margaret L ^a   Navaratnarajah, Maithili ^a   Nagarajan, Murali ^a   Cooney, Robert N ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Cytokine inflammation; Growth hormone resistance; Insulin like growth factor I; Janus kinase signal transducer and activator of transcription signaling; Mitogen activated protein kinase pathway; Serine protease inhibitor 2.1

Indexed keywords

DNA; GROWTH HORMONE RECEPTOR; INTERLEUKIN 6; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STAT5B PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA BINDING; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENETIC TRANSFECTION; HORMONE RESISTANCE; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CHROMATIN; GENES, REPORTER; HEPATOCYTES; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; LUCIFERASES; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); RATS; RECEPTORS, PROLACTIN; RECOMBINANT PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 34447508349     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00547.2006     Document Type: Article

References (65)

1. Ahmed T, Yumet G, Shumate M, Lang CH, Rotwein P, Cooney RN. Tumor necrosis factor inhibits growth hormone-mediated gene expression in hepatocytes. Am J Physiol Gastrointest Liver Physiol 291: G35-G44, 2006.
2. Ballinger AB, Azooz O, El-Haj T, Poole S, Farthing MJ. Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut 46: 694-700, 2000.
3. Ballinger AB, Camacho-Hubner C, Croft NM. Growth failure and intestinal inflammation. QJM 94: 121-125, 2001.
4. Belcher HJ, Ellis H. An investigation of the anabolic activity of somatropin in normal and burned rats. Burns 16: 17-20, 1990.
5. Bergad PL, Schwarzenberg SJ, Humbert JT, Morrison M, Amarasinghe S, Towle HC, Berry SA. Inhibition of growth hormone action in models of inflammation. Am J Physiol Cell Physiol 279: C1906-C1917, 2000.
6. Berry SA, Bergad PL, Stolz AM, Towle HC, Schwarzenberg SJ. Regulation of Spi 2.1 and 2.2 gene expression after turpentine inflammation: discordant responses to IL-6. Am J Physiol Cell Physiol 276: C1374-C1382, 1999.
7. Boisclair YR, Wang J, Shi J, Hurst KR, Ooi GT. Role of the suppressor of cytokine signaling-3 in mediating the inhibitory effects of interleukin-1beta on the growth hormone-dependent transcription of the acid-labile subunit gene in liver cells. J Biol Chem 275: 3841-3847, 2000.
8. Chow JC, Ling PR, Qu Z, Laviola L, Ciccarone A, Bistrian BR, Smith RJ. Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo. Endocrinology 137: 2880-2886, 1996.
9. Cooney R, Kimball SR, Eckman R, Maish G 3rd, Shumate M, Vary TC. TNF-binding protein ameliorates inhibition of skeletal muscle protein synthesis during sepsis. Am J Physiol Endocrinol Metab 276: E611-E619, 1999.
10. Cooney RN. Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway. Shock 17: 83-90, 2002.
11. Cooney RN, Kimball SR, Vary TC. Regulation of skeletal muscle protein turnover during sepsis: mechanisms and mediators. Shock 7: 1-16, 1997.
12. Dahn MS, Lange MP. Systemic and splanchnic metabolic response to exogenous human growth hormone. Surgery 123: 528-538, 1998.
13. Dahn MS, Lange MP, Jacobs LA. Insulinlike growth factor 1 production is inhibited in human sepsis. Arch Surg 123: 1409-1414, 1988.
14. Davey HW, Xie T, McLachlan MJ, Wilkins RJ, Waxman DJ, Grattan DR. STAT5b is required for GH-induced liver IGF-I gene expression. Endocrinology 142: 3836-3841, 2001.
15. De Benedetti F, Alonzi T, Moretta A, Lazzaro D, Costa P, Poli V, Martini A, Ciliberto G, Fattori E. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest 99: 643-650, 1997.
16. Defalque D, Brandt N, Ketelslegers JM, Thissen JP. GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors. Am J Physiol Endocrinol Metab 276: E565-E572, 1999.
17. Denson LA, Held MA, Menon RK, Frank SJ, Parlow AF, Arnold DL. Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3. Am J Physiol Gastrointest Liver Physiol 284: G646-G654, 2003.
18. Denson LA, Menon RK, Shaufl A, Bajwa HS, Williams CR, Karpen SJ. TNF-alpha downregulates murine hepatic growth hormone receptor expression by inhibiting Sp1 and Sp3 binding. J Clin Invest 107: 1451-1458, 2001.
19. DiFedele LM, He J, Bonkowski EL, Han X, Held MA, Bohan A, Menon RK, Denson LA. Tumor necrosis factor alpha blockade restores growth hormone signaling in murine colitis. Gastroenterology 128: 1278-1291, 2005.
20. Fan J, Char D, Bagby GJ, Gelato MC, Lang CH. Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor. Am J Physiol Regul Integr Comp Physiol 269: R1204-R1212, 1995.
21. Fan J, Wojnar MM, Theodorakis M, Lang CH. Regulation of insulin-like growth factor (IGF)-I mRNA and peptide and IGF-binding proteins by interleukin-1. Am J Physiol Regul Integr Comp Physiol 270: R621-R629, 1996.
22. Frost RA, Lang CH. Growth factors in critical illness: regulation and therapeutic aspects. Curr Opin Clin Nutr Metab Care 1: 195-204, 1998.
23. Galsgaard ED, Nielsen JH, Moldrup A. Regulation of prolactin receptor (PRLR) gene expression in insulin-producing cells. Prolactin and growth hormone activate one of the rat prlr gene promoters via STAT5a and STAT5b. J Biol Chem 274: 18686-18692, 1999.
24. Gebert CA, Park SH, Waxman DJ. Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation. Mol Endocrinol 11: 400-414, 1997.
25. Gebert CA, Park SH, Waxman DJ. Termination of growth hormone pulse-induced STAT5b signaling. Mol Endocrinol 13: 38-56, 1999.
26. Goodman MN. Interleukin-6 induces skeletal muscle protein breakdown in rats. Proc Soc Exp Biol Med 205: 182-185, 1994.
27. Groner B, Fritsche M, Stocklin E, Berchtold S, Merkle C, Moriggl R, Pfitzner E. Regulation of the trans-activation potential of STAT5 through its DNA-binding activity and interactions with heterologous transcription factors. Growth Horm IGF Res 10, Suppl B: S15-S20, 2000.
28. Hansen JA, Lindberg K, Hilton DJ, Nielsen JH, Billestrup N. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins. Mol Endocrinol 13: 1832-1843, 1999.
29. Hawker FH, Stewart PM, Baxter RC, Borkmann M, Tan K, Caterson ID, McWilliam DB. Relationship of somatomedin-C/insulin-like growth factor I levels to conventional nutritional indices in critically ill patients. Crit Care Med 15: 732-736, 1987.
30. Herrington J, Carter-Su C. Signaling pathways activated by the growth hormone receptor. Trends Endocrinol Metab 12: 252-257, 2001.
31. Herrington J, Smit LS, Schwartz J, Carter-Su C. The role of STAT proteins in growth hormone signaling. Oncogene 19: 2585-2597, 2000.
32. Kempe KC, Isom HC, Greene FE. Responsiveness of an SV40-immortalized hepatocyte cell line to growth hormone. Biochem Pharmacol 49: 1091-1098, 1995.
33. Lang CH, Fan J, Cooney R, Vary TC. IL-1 receptor antagonist attenuates sepsis-induced alterations in the IGF system and protein synthesis. Am J Physiol Endocrinol Metab 270: E430-E437, 1996.
34. Le Cam A, Paul C, Thissen JP. Growth hormone-mediated transcriptional activation of the rat serine protease inhibitor 2.1 gene involves both interleukin-1 beta-sensitive and -insensitive pathways. Biochem Biophys Res Commun 253: 311-314, 1998.
35. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A. The somatomedin hypothesis: 2001. Endocr Rev 22: 53-74, 2001.
36. Liao WS, Ma KT, Woodworth CD, Mengel L, Isom HC. Stimulation of the acute-phase response in simian virus 40-hepatocyte cell lines. Mol Cell Biol 9: 2779-2786, 1989.
37. Lieskovska J, Guo D, Derman E. IL-6-overexpression brings about growth impairment potentially through a GH receptor defect. Growth Horm IGF Res 12: 388-398, 2002.
38. Litterst CM, Kliem S, Lodrini M, Pfitzner E. Coactivators in gene regulation by STAT5. Vitam Horm 70: 359-386, 2005.
39. Lund PK. Insulin-like growth factor I: molecular biology and relevance to tissue-specific expression and action. Recent Prog Horm Res 49: 125-148, 1994.
40. Mao Y, Ling PR, Fitzgibbons TP, McCowen KC, Frick GP, Bistrian BR, Smith RJ. Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo. Endocrinology 140: 5505-5515, 1999.
41. Pao CI, Lin KW, Zhu J, Wu G, Farmer PK, Phillips LS. In vitro transcription of the rat insulin-like growth factor-I gene. J Biol Chem 271: 8667-8674, 1996.
42. Paul C, Seiliez I, Thissen JP, Le Cam A. Regulation of expression of the rat SOCS-3 gene in hepatocytes by growth hormone, interleukin-6 and glucocorticoids mRNA analysis and promoter characterization. Eur J Biochem 267: 5849-5857, 2000.
43. Pellegrini S, Dusanter-Fourt I. The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs). Eur J Biochem 248: 615-633, 1997.
44. Pfitzner E, Jahne R, Wissler M, Stoecklin E, Groner B. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response. Mol Endocrinol 12: 1582-1593, 1998.
45. Pircher TJ, Flores-Morales A, Mui AL, Saltiel AR, Norstedt G, Gustafsson JA, Haldosen LA. Mitogen-activated protein kinase kinase inhibition decreases growth hormone stimulated transcription mediated by STAT5. Mol Cell Endocrinol 133: 169-176, 1997.
46. Ram PA, Park SH, Choi HK, Waxman DJ. Growth hormone activation of Stat 1, Stat 3, and Stat 5 in rat liver. Differential kinetics of hormone desensitization and growth hormone stimulation of both tyrosine phosphorylation and serine/threonine phosphorylation. J Biol Chem 271: 5929-5940, 1996.
47. Ram PA, Waxman DJ. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase. J Biol Chem 272: 17694-17702, 1997.
48. Ram PA, Waxman DJ. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J Biol Chem 274: 35553-35561, 1999.
49. Sadeghi H, Wang BS, Lumanglas AL, Logan JS, Baumbach WR. Identification of the origin of the growth hormone-binding protein in rat serum. Mol Endocrinol 4: 1799-1805, 1990.
50. Sawczenko A, Azooz O, Paraszczuk J, Idestrom M, Croft NM, Savage MO, Ballinger AB, Sanderson IR. Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children. Proc Natl Acad Sci USA 102: 13260-13265, 2005.
51. Shoba LN, Newman M, Liu W, Lowe WL Jr. LY 294002, an inhibitor of phosphatidylinositol 3-kinase, inhibits GH-mediated expression of the IGF-I gene in rat hepatocytes. Endocrinology 142: 3980-3986, 2001.
52. Shumate ML, Yumet G, Ahmed TA, Cooney RN. Interleukin-1 inhibits the induction of insulin-like growth factor-I by growth hormone in CWSV-1 hepatocytes. Am J Physiol Gastrointest Liver Physiol 289: G227-G239, 2005.
53. Simar-Blanchet AE, Legraverend C, Thissen JP, Le Cam A. Transcription of the rat serine protease inhibitor 21 gene in vivo: correlation with GAGA box promoter occupancy and mechanism of cytokine-mediated down-regulation. Mol Endocrinol 12: 391-404, 1998.
54. Thissen JP, Verniers J. Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture. Endocrinology 138: 1078-1084, 1997.
55. Underwood LE, Thissen JP, Lemozy S, Ketelslegers JM, Clemmons DR. Hormonal and nutritional regulation of IGF-I and its binding proteins. Horm Res 42: 145-151, 1994.
56. Vanderkuur JA, Butch ER, Waters SB, Pessin JE, Guan KL, Carter-Su C. Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation. Endocrinology 138: 4301-4307, 1997.
57. Wang Y, Jiang H. Identification of a distal STAT5-binding DNA region that may mediate growth hormone regulation of insulin-like growth factor-I gene expression. J Biol Chem 280: 10955-10963, 2005.
58. Woelfle J, Billiard J, Rotwein P. Acute control of insulin-like growth factor-I gene transcription by growth hormone through Stat5b. J Biol Chem 278: 22696-22702, 2003.
59. Woelfle J, Chia DJ, Rotwein P. Mechanisms of growth hormone (GH) action. Identification of conserved Stat5 binding sites that mediate GH-induced insulin-like growth factor-I gene activation. J Biol Chem 278: 51261-51266, 2003.
60. Wojnar MM, Fan J, Frost RA, Gelato MC, Lang CH. Alterations in the insulin-like growth factor system in trauma patients. Am J Physiol Regul Integr Comp Physiol 268: R970-R977, 1995.
61. Woodworth CD, Isom HC. Regulation of albumin gene expression in a series of rat hepatocyte cell lines immortalized by simian virus 40 and maintained in chemically defined medium. Mol Cell Biol 7: 3740-3748, 1987.
62. Wyszomierski SL, Yeh J, Rosen JM. Glucocorticoid receptor/signal transducer and activator of transcription 5 (STAT5) interactions enhance STAT5 activation by prolonging STAT5 DNA binding and tyrosine phosphorylation. Mol Endocrinol 13: 330-343, 1999.
63. Yumet G, Shumate ML, Bryant DP, Lang CH, Cooney RN. Hepatic growth hormone resistance during sepsis is associated with increased suppressors of cytokine signaling expression and impaired growth hormone signaling. Crit Care Med 34: 1420 -1427, 2006.
64. Yumet G, Shumate ML, Bryant P, Lin CM, Lang CH, Cooney RN. Tumor necrosis factor mediates hepatic growth hormone resistance during sepsis. Am J Physiol Endocrinol Metab 283: E472-E481, 2002.
65. Zhu T, Goh EL, Graichen R, Ling L, Lobie PE. Signal transduction via the growth hormone receptor. Cell Signal 13: 599-616, 2001.